Molecular Mechanisms of Blood-Membrane Interactions in Hemodialysis: Advances in Anti-Inflammatory Surface Modifications.
- 1Department of Cardiac Surgery, Qingdao Central Hospital University of Health and Rehabilitation Sciences, No. 127 Siliu South Road, Shibei District, Qingdao 266042, China.
- 2Blood Purification Center, Qingdao Central Hospital University of Health and Rehabilitation Sciences, No. 127 Siliu South Road, Shibei District, Qingdao 266042, China.
- 3Department of Nephrology, Qingdao Central Hospital University of Health and Rehabilitation Sciences, No. 127 Siliu South Road, Shibei District, Qingdao 266042, China.
Abstract
The development of novel hemodialysis membranes aims not only to enhance dialysis efficiency but also to improve hemocompatibility, an important determinant of treatment safety and tolerability. This narrative review provides a comprehensive overview of the molecular mechanisms underlying blood-membrane interactions during hemodialysis, focusing on key processes such as protein adsorption, complement activation, platelet and leukocyte responses, oxidative stress, and inflammatory mediator release. These interconnected processes can contribute to acute blood-material incompatibility and thrombo-inflammatory responses during dialysis, although their contribution to long-term clinical outcomes remains multifactorial and incompletely defined. Furthermore, the review critically examines current surface-modification strategies, including hydrophilic and antifouling modifications, antithrombotic and complement-directed interfaces, and antioxidant functionalization. Particular emphasis is placed on distinguishing mechanistic and surrogate findings from clinically meaningful evidence and on considering hemocompatibility together with membrane transport performance. By integrating molecular mechanisms, modification strategies, and translational evidence, this review aims to provide a framework for the development and evaluation of safer and more effective hemodialysis membranes, while avoiding overinterpretation of isolated biomarker changes as established clinical benefit.
Related
- Commercial Oat‐Based Cosmetic Ingredients Promote Antioxidant Capacity and Reduce Inflammatory Markers in Skin Cellular Stress Models: An Insight Into Molecular Mechanisms In Vitro
- Lactylation-mediated remodeling of spatial immunometabolic niches in lung cancer: metabolic origins, cellular interactions, and molecular mechanisms
- Beyond Synovitis: Molecular and Neuroimmune Mechanisms Informing Target-Joint Attribution and Pain Phenotyping for Arthroplasty in Inflammatory Arthritis.
- Progress in research on RAAS inhibitors regulating inflammatory responses and oxidative stress: from molecular mechanisms to clinical evidence
- Effects of grinding penetration depth and abrasive grain spacing on atomic interactions and material removal mechanisms in silicon during ultrasonic vibration-assisted grinding: a molecular dynamics study
BibTeX
@article{wang2026molecular,
title = {{Molecular Mechanisms of Blood-Membrane Interactions in Hemodialysis: Advances in Anti-Inflammatory Surface Modifications.}},
author = {Jumiao Wang and Xiaoqi Jiang and Xiuyan Liu and Peiqiang Pan},
journal = {Membranes},
year = {2026},
month = oct,
doi = {10.3390/membranes16100332},
url = {https://europepmc.org/article/MED/42931010},
note = {CC BY},
}
RIS
TY - JOUR
TI - Molecular Mechanisms of Blood-Membrane Interactions in Hemodialysis: Advances in Anti-Inflammatory Surface Modifications.
AU - Jumiao Wang
AU - Xiaoqi Jiang
AU - Xiuyan Liu
AU - Peiqiang Pan
PY - 2026
DA - 2026/10/03
JO - Membranes
DO - 10.3390/membranes16100332
UR - https://europepmc.org/article/MED/42931010
AB - The development of novel hemodialysis membranes aims not only to enhance dialysis efficiency but also to improve hemocompatibility, an important determinant of treatment safety and tolerability. This narrative review provides a comprehensive overview of the molecular mechanisms underlying blood-membrane interactions during hemodialysis, focusing on key processes such as protein adsorption, complement activation, platelet and leukocyte responses, oxidative stress, and inflammatory mediator release. These interconnected processes can contribute to acute blood-material incompatibility and thrombo-inflammatory responses during dialysis, although their contribution to long-term clinical outcomes remains multifactorial and incompletely defined. Furthermore, the review critically examines current surface-modification strategies, including hydrophilic and antifouling modifications, antithrombotic and complement-directed interfaces, and antioxidant functionalization. Particular emphasis is placed on distinguishing mechanistic and surrogate findings from clinically meaningful evidence and on considering hemocompatibility together with membrane transport performance. By integrating molecular mechanisms, modification strategies, and translational evidence, this review aims to provide a framework for the development and evaluation of safer and more effective hemodialysis membranes, while avoiding overinterpretation of isolated biomarker changes as established clinical benefit.
SN - 2077-0375
ER -